PTCT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 66.09 USD -2.81% Market Closed

Market Cap: $5.5B

	PTC Therapeutics Inc NASDAQ:PTCT	US
T	TransDigm Group Inc F:T7D	US
V	Vinci SA XETRA:SQU	FR
A	Applied Materials Inc SWB:AP2	US

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

82%

Declining Gross Margin

94% > 93%

Healthy Operating Margin

12%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-42% > 12%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-13%

Net Margin is Increasing

-75% > -4%

Negative Free Cash Flow Margin

-4%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

-39% > -4%

Positive ROE

21%

Positive 3Y Average ROE

Positive 3Y Average ROIC

24%

ROIC is Increasing

-30% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.